AI-generated binders for targeted drug delivery
Company is active
Event Year: 2023
Company is active
Event Year: 2023
Nanograb is revolutionizing computational drug discovery by leveraging artificial intelligence to identify optimal combinations of binders for targeted disease treatment. Their innovative approach enables precise drug delivery to specific areas within the body, enhancing efficacy and minimizing side effects. By harnessing the power of AI, Nanograb aims to accelerate the development of novel therapeutics and improve patient outcomes in a variety of disease areas. This targeted approach represents a significant advancement in personalized medicine.
Nanograb is revolutionizing computational drug discovery by leveraging artificial intelligence to identify optimal combinations of binders for targeted disease treatment. Their innovative approach enables precise drug delivery to specific areas within the body, enhancing efficacy and minimizing side effects. By harnessing the power of AI, Nanograb aims to accelerate the development of novel therapeutics and improve patient outcomes in a variety of disease areas. This targeted approach represents a significant advancement in personalized medicine.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2023
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2023
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 5
Hiring: No
Team size: 5
Hiring: No
